Similar articles

• A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.

  Kirby TO, Rivera A, Rein D, Wang M, Ulasov I, Breidenbach M, Kataram M, Contreras JL, Krumdieck C, Yamamoto M, Rots MG, Haisma HJ, Alvarez RD, Mahasreshti PJ, Curiel DT. Kirby TO, et al. Clin Cancer Res. 2004 Dec 15;10(24):8697-703. doi: 10.1158/1078-0432.CCR-04-1166. Clin Cancer Res. 2004. PMID: 15623655
• Adenovirus infection inactivates the translational inhibitors 4E-BP1 and 4E-BP2.

  Gingras AC, Sonenberg N. Gingras AC, et al. Virology. 1997 Oct 13;237(1):182-6. doi: 10.1006/viro.1997.8757. Virology. 1997. PMID: 9344920
• [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].

  Sviatchenko VA, Tarasova MV, Netesov SV, Chumakov PM. Sviatchenko VA, et al. Mol Biol (Mosk). 2012 Jul-Aug;46(4):556-69. Mol Biol (Mosk). 2012. PMID: 23113343 Review. Russian.
• Sequence-specific interference by small RNAs derived from adenovirus VAI RNA.

  Sano M, Kato Y, Taira K. Sano M, et al. FEBS Lett. 2006 Mar 6;580(6):1553-64. doi: 10.1016/j.febslet.2006.01.085. Epub 2006 Feb 3. FEBS Lett. 2006. PMID: 16472808
• Inactivating intracellular antiviral responses during adenovirus infection.

  Weitzman MD, Ornelles DA. Weitzman MD, et al. Oncogene. 2005 Nov 21;24(52):7686-96. doi: 10.1038/sj.onc.1209063. Oncogene. 2005. PMID: 16299529 Review.